Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias-A...
Cardiovascular (CV) disease is the most common cause of death in Europe. Despite proven benefits, use of lipid-lowering therapy remains suboptimal. Treatment goals are often not achieved, even in...
pubmed.ncbi.nlm.nih.gov